Twitter | Pretraživanje | |
Amplyx Pharmaceuticals, Inc
Developing antifungal agents for the treatment of life-threatening invasive fungal infections due to Candida, Aspergillus and rare molds.
30
Tweetovi
66
Pratim
54
Osobe koje vas prate
Tweetovi
Amplyx Pharmaceuticals, Inc proslijedio/la je tweet
Antimicrobials Working Group 31. sij
The Benchmark Report shows that, despite some progress, R&D has not increased enough to radically impact the problem of AMR. New legislation and regulations are needed to address the broken market and spur new life saving development
Reply Retweet Označi sa "sviđa mi se"
Amplyx Pharmaceuticals, Inc proslijedio/la je tweet
Antimicrobials Working Group 29. sij
Immediate action is needed to help the companies working to fight . Learn how legislation like the can help stabilize the antimicrobial market and spur the development of life-saving treatments:
Reply Retweet Označi sa "sviđa mi se"
Amplyx Pharmaceuticals, Inc proslijedio/la je tweet
Antimicrobials Working Group 23. sij
is evolving faster than new development. It is critical that policy makers fix the broken market. Learn more about the rising threat of and how legislation like the that has potential to help
Reply Retweet Označi sa "sviđa mi se"
Amplyx Pharmaceuticals, Inc 22. sij
Hope on the Horizon: Novel Fungal Treatments in Development via
Reply Retweet Označi sa "sviđa mi se"
Amplyx Pharmaceuticals, Inc 22. sij
Reply Retweet Označi sa "sviđa mi se"
Amplyx Pharmaceuticals, Inc proslijedio/la je tweet
CHARM UC San Diego 18. sij
“We still have a window of opportunity but we need to ensure there is investment now so we don’t run out of options for future generations.”
Reply Retweet Označi sa "sviđa mi se"
Amplyx Pharmaceuticals, Inc proslijedio/la je tweet
Helen Boucher 16. sij
Very important session starting - join the discussion on line
Reply Retweet Označi sa "sviđa mi se"
Amplyx Pharmaceuticals, Inc proslijedio/la je tweet
Antimicrobials Working Group 17. sij
Without new action, the threat of will only grow. shares 5 priorities to combat AMR in 2020, including the use of economic incentives and passing the to catalyze the development of new life-saving :
Reply Retweet Označi sa "sviđa mi se"
Amplyx Pharmaceuticals, Inc proslijedio/la je tweet
Antimicrobials Working Group 5. pro
Lord Jim O'Neill calls for death certificates to include '' as cause of death in an effort to raise awareness of the crisis and improve the data scientists have to work with. via
Reply Retweet Označi sa "sviđa mi se"
Amplyx Pharmaceuticals, Inc proslijedio/la je tweet
Antimicrobials Working Group 2. pro
Almost 3 million resistant infections occur each year in the U.S. ' details the immense threat poses & ongoing efforts such as the DISARM Act to fix the broken market & spur antimicrobial development:
Reply Retweet Označi sa "sviđa mi se"
Amplyx Pharmaceuticals, Inc 21. stu
Why the CDC warns antibiotic-resistant fungal infections are an urgent health threat via
Reply Retweet Označi sa "sviđa mi se"
Amplyx Pharmaceuticals, Inc 18. stu
Dr. Karen Shaw will present "Fighting Infections with Fosmanogepix: A first-in-class Antifungal Agent" at the CHARM UC San Diego meeting tomorrow from 4-7pm. Hope to see you there!
Reply Retweet Označi sa "sviđa mi se"
Amplyx Pharmaceuticals, Inc proslijedio/la je tweet
IDSA 18. stu
IDSA’s Faces of Antimicrobial Resistance report highlights patients & their families who have suffered the debilitating effects of infections. These heart-wrenching stories demonstrate the urgent need to combat .
Reply Retweet Označi sa "sviđa mi se"
Amplyx Pharmaceuticals, Inc 13. stu
Drug-Resistant Candida auris is now recognized as an URGENT Threat by the CDC, with an increasing number of strains resistant to all available therapies. New classes of antifungal therapies are needed!
Reply Retweet Označi sa "sviđa mi se"
Amplyx Pharmaceuticals, Inc proslijedio/la je tweet
Antimicrobials Working Group 1. stu
In order to spur action necessary to support innovation, we must continue to effectively communicate how drug-resistance undermines and can affect everyone. Learn how from :
Reply Retweet Označi sa "sviđa mi se"
Amplyx Pharmaceuticals, Inc proslijedio/la je tweet
Antimicrobials Working Group 1. stu
. President & CEO highlights the urgent need for new policies like the that will spur the development of novel to fight in his Op-Ed.
Reply Retweet Označi sa "sviđa mi se"
Amplyx Pharmaceuticals, Inc 31. lis
A future without new antimicrobial therapies to address infections caused by resistant pathogens is truly SCARY! At Amplyx, we are proud to be developing innovative therapies for patients at risk for these often life-threatening infections.
Reply Retweet Označi sa "sviđa mi se"
Amplyx Pharmaceuticals, Inc proslijedio/la je tweet
Erin McCreary 26. lis
Odgovor korisniku/ci @JGPharmD
.: "antifungal resistance is rising and if you aren't testing, you don't know."
Reply Retweet Označi sa "sviđa mi se"
Amplyx Pharmaceuticals, Inc proslijedio/la je tweet
Erin McCreary 26. lis
Odgovor korisniku/ci @JGPharmD
.: "antifungal resistance is likely underappreciated since many institution do not routinely test Candida species susceptibilities" C. auris concerning due to multi-drug resistance + it is extremely hard to eradicate.
Reply Retweet Označi sa "sviđa mi se"
Amplyx Pharmaceuticals, Inc 17. lis
We are proud to be a part of the 3X5 family! Sustainability, Life Sciences Investor 3x5 Doubles Team Amid Fundraising
Reply Retweet Označi sa "sviđa mi se"